Core Viewpoint - Zentek Ltd. has successfully closed a non-brokered private placement of units, raising gross proceeds of $2,479,227 through the issuance of 2,338,893 units at a price of $1.06 per unit [1][2]. Group 1: Offering Details - Each unit consists of one common share, one-half of a Series A warrant, and one-half of a Series B warrant [2]. - The Series A warrant allows the holder to purchase one common share at $1.50 until October 22, 2027, with potential acceleration of the expiry date if the share price reaches $2.00 for 10 consecutive trading days [3]. - The Series B warrant allows the holder to purchase one common share at $2.00 until October 22, 2028, with potential acceleration if the share price reaches $3.00 for 10 consecutive trading days [4]. Group 2: Financial Aspects - The company paid finder fees totaling $35,429.33 and issued finder warrants for the purchase of 33,424 units at $1.06 per unit until October 22, 2027 [5]. - Proceeds from the offering will be utilized for general and administrative corporate purposes [6]. Group 3: Company Background - Zentek is an intellectual property development and commercialization company focused on enhancing product safety and efficiency through innovative technologies [11]. - The company’s patented ZenGUARD™ technology improves viral filtration efficiency for surgical masks and HVAC systems, with production facilities located in Guelph, Ontario [12].
Zentek Announces Closing of Non-Brokered Private Placement of Units for Gross Proceeds of $2,479,227